Detection of clonal T cell receptor ␥ (TCRG) gene rearrangements by PCR is widely used in both the diagnostic assessment of lymphoproliferative disorders and the follow-up of acute lymphoblastic leukaemia (ALL), when residual positivity in excess of 10 −3 at morphological complete remission is increasingly recognised to be an independent marker of poor prognosis. This is largely based on specific detection of V-J rearrangements from childhood cases. We describe rapid, multifluorescent V␥ and J␥ PCR typing of multiplex amplified diagnostic samples, as applied to 46 T-ALL. These strategies allow selected analysis of appropriate cases, immediate identification of V␥ and J␥ segments in over 95% of alleles, improved resolution and precision sizing and a sensitivity of detection at the 10 −2 -10 −3 level. We demonstrate preferential V-J combinations but no difference in V-J usage between children and adults, nor between SIL-TALI-negative and -positive cases. A combination of fluorescent multiplex and V␥-J␥-specific monoplex follow-up, as described here, will allow detection of both significant clonal evolution and of the diagnostic clone at a level of prognostic significance, by techniques which can readily be applied to large-scale prospective studies for which real-time analysis is required.
Introduction
Detection of clonal T cell receptor ␥ (TCRG) gene rearrangements is widely used in both the diagnostic assessment of lymphoproliferative disorders and the detection of minimal residual disease (MRD) in acute lymphoblastic leukaemia (ALL). While initial analyses were performed by Southern blotting (SB), these are increasingly done by the polymerase chain reaction (PCR) from DNA. PCR detection of clonal TCR or immunoglobulin (Ig) gene rearrangements exploits the fact that polyclonal lymphoid populations generate products which demonstrate a Gaussian distribution as a result of the variable length and nucleotide sequence of the heterogeneous V-(D)-J junctional sequences, whereas a clonal population, with identical V-(D)-J sequences, will generate discrete band(s), depending on the number of rearranged alleles. TCRG represents a preferential target for PCR analyses since it is rearranged at an early stage of T lymphoid development in both TCR␣␤ and TCR␥␦ lineage precursors and in the majority of B lineage ALLs. It contains a limited number of V␥ and J␥ segments, thus allowing amplification of all major V␥-J␥ combinations with a limited number of specific primers. The human TCRG locus contains 14 V␥ segments, only 10 of which have been shown to undergo rearrangement ( Figure 1a ). The expressed V␥ repertoire includes only six V␥ genes (V␥2, V␥3, V␥4, V␥5, V␥8 and V␥9) but rearrangement also occurs with the V␥7, V␥10, V␥11.
2 V␥10 and V␥11 have recently been shown to be pseudogenes, due to absence of splicing of their leader introns. 3 Rearranging V␥ segments can be subdivided into those belonging to the V␥I family (V␥2, V␥3, V␥4, V␥5, V␥7 and V␥8) and the single member V␥9, V␥10, V␥11 families. Within V␥fl, the highest levels of homology (95%) exist between V␥2 and V␥4 and V␥3 and V␥5, reflecting probable gene duplication. 4 Of the five J␥ segments (J␥P1 (J␥1. 5 It is therefore possible to identify all possible V␥-J␥ combinations using four V␥ and three J␥ primers (Figure 1b and c) .
Whilst the restricted germline-encoded repertoire facilitates PCR amplification, the limited junctional diversity of TCRG rearrangements complicates distinction of clonal from polyclonal PCR products. Junctional diversity results from the incorporation of diversity (D) segments and N and P (palindromic) nucleotides and the removal of germline-encoded nucleotides at the extremities of the V, D and J segments. The TCRG locus does not contain D segments and demonstrates relatively limited nucleotide additions, at least in ALL, where the average number of added nucleotides is six. 6 TCRG V-J junctional length therefore varies by approximately 20 bp, whereas TCRD and IGH junctional length varies by approximately 60 bp. 7, 8 It is therefore extremely important to analyse TCRG PCR products using high resolution electrophoretic techniques. A further possible source of false positivity results from the presence of TCR␥␦ expressing T lymphocytes demonstrating 'canonical' TCRG rearrangements which do not demonstrate N nucleotide additions. The most commonly recognised human canonical TCRG rearrangement involves the V␥9-J␥P segments and occurs in approximately 1% of PBL.
9,10

Figure 1
(a) Schematic representation of the TCRG locus. Functional V␥ segments are shown in black. V␥7, V␥10 and V␥10 can be involved in V␥-J␥ rearrangement, despite being pseudogenes. (b) Localisation of V␥ primers. V␥fI refers to a consensus family I primer. V␥XS refers to specific primers. Black arrows indicate unlabelled primers used in initial EB-PAGE multiplex screening, some of which (V␥9-11) were also used as specific primers. (c) Localisation of J␥ primers. The internal (INT)-labelled primers were used in FluRO analysis and the externallabelled primers in direct fluorescent analysis.
Several strategies for the detection of minor clonal TCRG populations have been described. The most sensitive and specific involve sequencing of the clonal V␥-J␥ junction and synthesis of an allele-specific oligonucleotide (ASO) which is then used as a hybridisation probe. 6, 11, 12 The sensitivity of such strategies is approximately 10
. Their clinical use in ALL follow-up has demonstrated that a significant proportion of patients remain PCR positive during apparent complete remission but that an increased risk of relapse is most marked for patients who demonstrate levels of residual positivity in excess of 10 −2 -10 −3 . 11,12 While these strategies represent optimal specificity and sensitivity they are labour intensive and do not permit detection of clonal evolution. It is therefore possible that simpler strategies which provide a level of detection intermediate to the 5% level of non-denaturing PAGE and ASO methods may be more easily applicable to large-scale clinical follow-up.
Analysis of fluorescent PCR products on automated DNA fragment analysers represents a simple, reliable, non-toxic form of high resolution analysis which is widely used for the analysis of expressed TCR␤ repertoires following reverse transcriptase PCR (RT-PCR) with family specific V␤ and C␤ primers and internal, linear fluorescent J␤ run-off reactions. 13 It has also been applied to analysis of IGH genomic repertoires, using consensus primers and monofluorescence. 8 In this study, we have developed a two-stage multiplex PCR strategy for the rapid detection of TCRG clonality and subsequent multifluorescent identification of V␥ and J␥ segment utilisation. It allows identification of virtually all recognised V␥-J␥ combinations in two PCR reactions with a maximum of three fluorescent run-off reactions. We have tested the applicability of this approach on a panel of T-ALLs, both with regard to informativity and sensitivity. These strategies will allow improved identification of V␥ and J␥ segment utilisation and detection of minor clonal populations at a level which may have clinical relevance.
Materials and methods
Leukaemic samples
Diagnostic samples from T-ALL blood or bone marrow were obtained with patient consent and separated by density gradient separation using Ficoll (Pharmacia, Sweden) prior to immunophenotype and genotype analysis, either immediately or after cryopreservation in 10% DMSO. Immunophenotyping for surface expression was performed by indirect staining and flow cytometric analysis, using classical techniques and a panel of T and B lymphoid and myeloid antigens.
TCRG rearrangements Ethidium bromide-stained polyacrylamide gel electrophoresis (EB PAGE):
DNA was isolated by phenol-chloroform extraction after digestion with proteinase K. Detection of a clonal TCRG population was undertaken by PCR amplifi-cation of TCRG genes from DNA, modified from Ref. 6 to allow multiplex detection of all major V␥-J␥ combinations in two PCR reactions. Both reaction mixes included three J␥ primers (J␥P, J␥P1/2, J␥1/2) capable of recognising all five known J␥ segments. 2, 5 V␥ primers included a consensus V␥fI primer (V␥2, V␥3, V␥4, V␥5, V␥7 and V␥8) and specific primers for the V␥9, V␥10 and V␥11 segments. All primer sequences are shown in Table 1 and their positions in Figure 1b and c. The mixes were designed to allow partial determination of V␥ usage on the basis of PCR product size. The first mix (V␥fI/V␥10) detects rearrangements involving the V␥I family (PCR product size 230-280 base pairs (bp)) and V␥10 TCRG (160-190 bp) gene segments. The second mix (V␥9/V␥11) detects rearrangements involving the V␥9 (230-280 bp) and V␥11 (140-170 bp) segments.
PCR were performed on an automated thermocycler (Biometra, Gö ttingen, Germany) using 1 g DNA template, 1 U Taq polymerase (Boerhinger, Mannheim, Germany) and 0.5 M each primer, 0.2 mM dNTPs, 2.5 mM MgCl 2 in a total volume of 50 l. DNA was denatured at 92°C for 5 min, followed by 35 cycles consisting of denaturation for 30 s, primer annealing for 1 min at 57°C and extension for 1 min 72°C, prolonged to 10 min for the last cycle. For ethidium bromide 29:1 PAGE (EB-PAGE) analysis (Eurobio, Les Ulis, France), 15 l of PCR product were size-separated on 8% 20-cm nondenaturing gels, run in 0.5× TBE (Tris, Borate, EDTA) and visualized under UV illumination. In order to maximise heteroduplex formation, PCR samples were heated at 99°C for 3 min, at 65°C for 3 min, then cooled to 4°C prior to electrophoresis. A clonal population of T cells corresponded to a discrete band visible within the size range predicted for each set of primers. These primers were also used for specific PCR. S = specific. For direct fluorescent analysis, identical J␥1/2-TET, J␥P-HEX and J␥P1/2-6FAM labelled primers were used.
Leukemia
Run-off PCR:
High resolution analysis and partial determination of V␥ and J␥ segment usage of PCR products was undertaken by rendering them fluorescent prior to analysis on an automated DNA fragment analyser. Fluorescent primers were provided by PE biosystems. For cases demonstrating approximately 250 bp fragments with the V␥I/V␥10 reaction mix, PCR products were incubated with a mixture of internal TCRG V␥ primers specific for the V␥2 and V␥4 (V␥2/4 INT-6FAM), V␥3 and V␥5 (V␥3/5 INT-HEX) and V␥8 (V␥8 INT-TET) segments labelled with three different fluorophores, as indicated, in a limited cycle, linear amplification of V␥fI PCR products, adapted from fluorescent IGH run-off (FluRO) strategies 8 ( Table 1 and Figure 1b ). Identification of J␥ usage for V␥fl/V␥10 and V␥9/V␥11 PCR products was undertaken by FluRO analysis with a mix of three internal J␥ primers, J␥1/2 INT-6FAM, J␥P INT-HEX and J␥P1/2 INT-TET (Table 1 and Figure 1c ). FluRO reactions contained 2.1 mM MgCl 2 0.15 mM dNTP, 0.25 M of each fluorescent primer (0.5 M J␥P-HEX), 0.25 U Taq polymerase and 2 l PCR product in a total volume of 12 l and were amplified for seven cycles comprising 1 min denaturation at 95°C, 1 min hybridization at 64°C and 1 min elongation at 72°C. TCRG FluRO products (2 l) were denatured by heating to 95°C for 2 min in the presence of formamide followed by rapid cooling to 4°C prior to analysis on an ABI373 DNA fragment analyser (PE Biosystems, Roissy, France), using 10% denaturing PAGE, 1 × TBE buffer at 1000 V for 4 h. Results were analysed using Genescan 672 software.
Direct fluorescence:
Direct fluorescence analysis was performed by inclusion of J␥1/2-TET, J␥P-HEX and J␥P1/2-6FAM (with the same sequence as the external J␥ primers used in EB PAGE; Table 1 and Figure 1c ) at a final concentration of 0.25 M in the initial PCR (35 cycles) and analysis of 1 l of PCR product on an ABI310 DNA fragment analyser using POP4 polymer (PE Biosystems).
Specific V␥ PCR:
Verification of TCRG V␥fI segment utilisation in selected cases was undertaken by specific monoplex PCR using the V␥ specific primers shown in Table 1 and Figure 1b and the reaction conditions indicated above. Specific PCR reactions were analysed by 8% non-denaturing PAGE. For sensitivity testing DNA samples were diluted into PBL polyclonal DNA or a 10% PBL/90% U937 mix prior to amplification.
Cloning and sequencing of TCRG PCR products
PCR products were purified from agarose gels and cloned in pGemT-easy vector (Promega, Madison, WI, USA), as indicated by the manufacturer. Nucleotide sequence was determined by the dideoxynucleotide method using the ABI373 sequencing apparatus with the M13 dye-primer sequencing kit, as indicated by the manufacturer (PE Biosystems).
SIL-TAL1 detection
SIL-TAL1 fusion transcripts were detected by RT-PCR from RNA, as previously described.
Results
Multiplex TCRG PCR EB PAGE analysis (Figures 1 and 2a)
For routine diagnostic detection of clonal populations, we developed two multiplex PCR mixes (V␥fI/V␥10 and V␥9/V␥11) which allow detection of all V␥-J␥ rearrangements. All DNA samples were routinely tested with both mixes and analysed on ethidium bromide-stained PAGE (EB PAGE). They were considered positive if one or the other demonstrated at least one discrete band. PCR products with V␥fI/V␥10 generated approximately 250 bp bands from V␥fI-J␥ rearrangements and approximately 170 bp bands from V␥10-J␥ rearrangements. V␥9 PCR products measured approximately 250 bp and V␥11 products approximately 150 bp. It was not possible to determine J␥ utilisation on the basis of size. Each PCR experiment included control reactions without DNA, a polyclonal PBL negative control and the PEER T cell line (V␥8-J␥2 and V␥9-J␥2) clonal positive control at log dilutions into PBL DNA (Figure 2a ). Repeated analysis showed the 100% positive control to be strongly positive, the 10% control reproducibly weakly positive, and the 1% control negative or at the limit of detection, thus limiting the sensitivity of detection to approximately 5%.
TCRG fluorescent run-off analysis (FluRO) Polyclonal samples:
V␥ utilisation: V␥ segment identification for V␥fI members was performed by fluorescent analysis of appropriately-sized positive V␥fI/V␥10 PCR products after limited cycle linear run-off amplification (FluRO) with a mixture of internal V␥2/V␥4, V␥3/V␥5 and V␥8 fluorescent internal primers, generating fluorescent PCR products of approximately 140 bp (Figure 1b) . No attempt was made to distinguish V␥2 from V␥4 and V␥3 from V␥5 by FluRO analysis, although this was determined by specific PCR in appropriate cases. Two overlapping Gaussian peaks were observed for V␥2/4, reflecting the fact that the V␥4 segment is 21 bp longer than V␥2 (Figures 1B and 3 ). J␥ utilisation: J␥ utilisation was determined by the incorporation of one of a mix of three internal J␥-labelled primers on V␥fI/V␥10 and V␥9/V␥11 PCR, when positive by EB-PAGE. Two J␥1/2 and J␥P1/2 peaks were demonstrated in V␥fI/V␥10 PBL samples (Figure 3a) , the larger corresponding to V␥fI members and the smaller to rearrangements involving V␥10. Incorporation of J␥P into V␥fI and V␥10 rearrangements was rare. FluRO analysis of V␥9/V␥11 PCR products demonstrated predominantly V␥9-J␥1/2 rearrangements and a small number of V␥9-J␥P which varied from virtually absent to the expected restricted number of peaks with a 3 bp size distribution. V␥9-J␥P1/2 and V␥11 rearrangements were rare.
T-ALL:
The applicability of FluRO TCR V␥ and J␥ determination was tested on 46 T-ALLs, all of which demonstrated cytoplasmic CD3 (cCD3) positivity. EB PAGE analysis ( Figure 2 ) demonstrated at least one clonal band in all but one case. Eight (17%) demonstrated a single band in the V␥fI/V␥10 PCR and V␥9/V␥11 negativity, compatible with a monoallelic V␥-J␥ rearrangement. V␥9/V␥11 PCR demonstrated a single band in seven cases (two V␥9, five V␥11), all of which also showed a monoallelic V␥fI/V␥10 rearrangement, and a bi-allelic V␥9 and V␥11 rearrangement in one case (UPN 219).
V␥ and J␥ FluRO analysis was performed on all V␥fI/V␥10-positive cases and J␥ on all V␥9/V␥11-positive cases. The V␥ and J␥ primers were specific when used in a multiplex run-off, although appropriate dilution of FluRO products was necessary to avoid 'cross-fluorescence' due to over-loading. V␥ and J␥ assignment was clear in the majority of cases, as detailed in Table 2 and as shown for selected cases in Figure 3b . Three cases classified as monoallelic on ethidium bromide analysis were shown to have undergone bi-allelic V␥fI-J␥1/2 rearrangement by FluRO, with the peaks separated by less than 10 bp (Figure 3b, UPN1126) . Retrospectively, the presence of heteroduplex bands in two of these cases, with biallelic V␥4-J␥1/2 (UPN 1126) and V␥5-J␥1/2 and V␥2-J␥1/2 (UPN 94) rearrangements, should have been suggestive a b
Figure 3
FluRO profiles of TCRG amplified PCR polyclonal PBL (a) or clonal T-ALL (b) samples. V␥ and J␥ identification is given by the fluorophore incorporated, as indicated. The type of multiplex PCR and the internal labelled mix is indicated on the left. PCR product size and fluorescent intensity is also shown.
of bi-allelic rearrangements. In general, heteroduplex formation was observed in the majority of cases having undergone the same V␥fI member-J␥ rearrangement on both alleles but was also seen between certain V␥fI members. This was neither constant, nor was it obviously restricted to specific pairs of V␥ segments. Fluorescent intensity differed between the two alleles, particularly, but not exclusively, when V␥ or J␥ utilisation differed (see UPN 1026 in Figure 3b ). Fluorescent intensity cannot therefore be used in these conditions to accurately assess the proportion of cells with a given rearrangement.
Informativity:
FluRO analysis allowed J␥ determination in 81/82 alleles (99%) from the 46 patients. The single unidentified J␥ allele (UPN 1613) was shown to correspond to a V␥3/5-J␥1/2 rearrangement by V␥ FluRO and J␥-specific PCR, respectively. Sequence analysis of this rearrangement confirmed a V␥3-J␥1/2 with no J␥ mismatch to explain the failure of the internal J␥1/2 primer to recognise the V␥fI-J␥1/2 PCR product (data not shown and see below).
Subtyping of V␥fI members allowed detection of all V␥8 and V␥3/5 rearrangements. Eleven alleles from nine patients (UPN 54, 94, 1026, 1029, 1126, 1314, 1456, 1613 and 1813) Leukemia demonstrated a V␥fI-J␥ rearrangement using a consensus V␥fI primer which was detected by the J␥1/2 INT-6FAM fluorescent primer, but not by the three V␥ fluorescent primers. Specific PCR analyses demonstrated that this was due to a V␥7 rearrangement for two alleles (UPN 1456 and 1813) and failure of the V␥2/4 INT-6FAM primer to recognise eight V␥4 rearrangements and one V␥2 rearrangement. This was likely to be due to the fact that the C nucleotides at positions 2 and, more importantly, 15, of V␥2/4 INT-6FAM were complementary to V␥2 but not to V␥4, when they were represented by a G. V␥2/4 INT-6FAM was therefore modified by adding one 5Ј nucleotide and introducing a C/G degeneracy (V␥2/4 INT2-6FAM) at position 15, as shown in Table 1 . The V␥2 and 7/8 V␥4 and rearrangements were detected with V␥2/4 INT2-6FAM, although in one V␥4 (UPN 1314), the fluorescent intensity was at the limit of detection. Sequence analysis of this case confirmed a V␥4-J␥1/2, with a PCR product size compatible with that observed on V␥2/4 INT2-6FAM FluRO analysis. No mutation was observed in the sequences recognised by either the V␥2/4 INT-6FAM or V␥2/4 INT2-6FAM FluRO primers (data not shown). This case demonstrated a V␥3/5-J␥1/2 rearrangement on the other allele, confirmed by sequence analysis. The only remaining T-ALL was the single case (UPN 1613) in which a J␥1/2 rearrangement was not recognised by FluRO. This case therefore demonstrated a V␥3-J␥1/2 of 247 bp which was recognised by the V␥3/5 INT-HEX but not by the J␥1/2INT-6FAM and a V␥4-J␥2 of 248 bp recognised by J␥1/2 INT-6FAM but not by V␥2/4 INT2-6FAM. Sequence analysis of both alleles failed to identify any mismatches within the target sequences for the FluRO primers (data not shown). We therefore amplified both alleles using V␥3S and V␥4S specific primers and either J␥1/2 or J␥1/2-TET, which have identical sequences and differe only by the presence of the fluorophore. Primer concentration was identical in all reactions. As shown in Figure 2b , both alleles were amplified with unlabelled J␥1/2, using either consensus or specific V␥ primers. The V␥4-J␥1/2 allele was also amplified, albeit very weakly, with J␥1/2-TET, whereas this primer failed to amplify the V␥3-J␥1/2 allele. We therefore conclude that the presence of the fluorophore in both J␥1/2 INT-6FAM and J␥1/2-TET led to failure of amplification in this case.
Analysis of cases detected by the initial V␥2/4 INT-6FAM fluorescent primer demonstrated that these were predominantly V␥2, with only 2/10 tested involving V␥4. Retesting with V␥2/4 INT2-6FAM demonstrated that both V␥4-J␥1/2 and one V␥2-J␥1/2 rearrangements were poorly identified with the latter, although they were not completely negative. We therefore now routinely use the V␥2/4 INT2-6FAM primer but retest with V␥2/4 INT-6FAM and with a V␥7-specific PCR if the V␥ FluRO is negative in the presence of a V␥fI-sized fragment and J␥ FluRO positivity.
In total, V␥ identification by evaluation of PCR product size on EB PAGE (V␥9-11) and V␥ FluRO was successful in typing of 79/82 (96%) V␥ alleles, the three undetected alleles corresponding to two V␥7-J␥1/2 and one V␥4-J␥1/2.
V␥ and J␥ utilisation
The majority of rearrangements involved the V␥fI (66/82; 80%) and J␥1/2 (68/82; 83%) segments ( Table 2 ). The overall incidence of V␥2/4 and V␥3/5 rearrangement was similar and both were rearranged to J␥1/2 in all but four alleles (45/49; 92%). V␥8 rearrangements represented 20% of alleles and a higher proportion (5/16; 31%) involved J␥P1/2. Rearrangements involving the V␥7 pseudogene were rare and the V␥10 and V␥11 pseudogenes were found in four and six alleles, respectively. Overall, pseudogenes were involved in 15% of rearrangements. Fifty percent of V␥11 rearrangements involved J␥P1/2. In total, J␥P1/2 rearrangements were found in 16% of alleles and involved J␥-proximal V␥ segments in the majority (V␥8-11 in 10/13 alleles). They were overrepresented (4/8) in cases with monoallelic TCRG rearrangements. A single, monoallelic, J␥P rearrangement, confirmed by specific V␥3/5-J␥P PCR, was observed.
One T-ALL (UPN 1769) demonstrated a normal-sized V␥8-J␥1/2 rearrangement and an approximately 70 bp V␥fI-J␥1/2 fragment on EB PAGE, which was shown to be a V␥2-J␥1/2 on specific amplification with V␥2S ( Figure 2b ). Based on the size, this is likely to correspond to a V␥2-J␥1/2 rearrangement which has undergone internal deletion. 
TCR V␥-J␥ as a function of age and SIL-TAL1 expression (Table 2)
Twenty-eight cases (61%) were aged less than 15 years. The proportion of childhood cases undergoing J␥P1/2 rearrangement was higher than in adults, but no other significant differences were observed, including in V␥2 vs V␥4 and V␥3 vs V␥5 usage.
The SIL-TAL1 fusion transcript is found in approximately 20% of childhood and 10% of adult T-ALL. 14 The present series included 12 SIL-TAL1-positive cases, the majority of which were children. No differences in TCRG usage in this group were observed on comparison with the overall group or with the paediatric subgroup ( Table 2 ). It is noteworthy that, while monoallelic TCRG rearrangements were seen in 7/31 (23%) SIL-TAL1-negative cases, all SIL-TAL1-positive cases had undergone bi-allelic rearrangement (Table 2) .
Sensitivity (Figure 4)
In order to estimate the sensitivity of detection of the fluorescent strategies, we initially performed dilutions of clonal DNA from the Peer T lymphoid line and one T-ALL (UPN 1029) into polyclonal PBL DNA. Sensitivity of detection of the appropriately sized bands after multiplex PCR and EB PAGE varied from 2.5 to 10%. FluRO analysis with the internal J␥ primers used above led to a minor, two-to four-fold, improvement in sensitivity for two of the four alleles tested. In contrast, V␥ and fluorescent J␥-specific PCR with direct analysis led to a 10-to 200-fold improvement in sensitivity for three of the four alleles. Direct fluorescent analysis was therefore chosen for further evaluation.
Since competition from polyclonal TCRG rearrangements Table 1. significantly reduces sensitivity, both due to competition for reagents and loss of the clonal peak within the Gaussian population, dilution into PBL DNA is not representative of bone marrow assessment, when the proportion of polyclonal rearrangements is lower, particularly at early stages following induction chemotherapy. We therefore tested six TCRG rearrangements from three T-ALLs by multiplex and V␥-J␥-specific direct fluorescent PCR following dilution into a mixture of 10% PBL in U937 myeloid cell line DNA, to simulate early remission bone marrow conditions. The V␥-specific Leukemia (V␥S) and labelled external J␥ primers from Table 1 were used. PCR products were analysed both by EB PAGE and fluorescence analysis. As shown in Figure 4 , multiplex amplification allowed detection at the 2.5-5 × 10 −2 level (mean 3.3 × 10 ). Variability between alleles for a given T-ALL was up to 1 log and depended predominantly on the position of the clonal peak with respect to the polyclonal peaks. In each of the three cases tested, the peak within the polyclonal size range was detected at 5 × 10 −3 and the peak outside this range at 5 × 10 −4 . These data demonstrate that improved sensitivity can be obtained with fluorescent and/or V␥-J␥-specific strategies and that both are necessary to obtain reproducible detection at the 5 × 10 −3 (0.5%) level, demonstrated to be of prognostic significance for early molecular assessment in ALL at achievement of complete remission. 11, 12 It should, however, be emphasised that the V␥-J␥ specific fluorescent PCR analyses were not optimised to maximise specificity, being used under multiplex PCR conditions. It is therefore possible that their potential sensitivity is higher.
Discussion
The aim of this study was to use T-ALLs to evaluate the use of a multifluorescent PCR strategy for efficient identification of TCR V␥ and J␥ utilisation in ALL, with a view to improving simplified molecular follow-up. We chose to develop a twostage strategy based on two multiplex reactions analysed by heteroduplex non-denaturing EB PAGE which are used for all diagnostic indications for TCRG clonality analysis, thus limiting more extensive (and expensive) fluorescent analysis to selected cases. The former have now been used in our laboratory for the analysis of over 1000 diagnostic DNA samples. They provide a reproducible sensitivity of 1-10%, as demonstrated here, and rarely given non-specific bands which could be interpreted as minor clonal populations, at least in younger individuals. Partial V␥ segment identification (V␥fI, V␥9, V␥10, V␥11) is possible on the basis of PCR product size. Caution is obviously required with regard to canonical V␥9-J␥P rearrangements, but this is rarely a problem once their existence and profile is recognised. A single multiplex TCRG reaction incorporating eight V␥ and three J␥ primers has been described. 16 Individual V␥ primers for the V␥fI members were used, potentially explaining the high proportion of cases (53%) which demonstrated three V␥-J␥ primer combinations when the multiplex primer mix was split. In our experience, it is difficult to obtain specific amplification of V␥fI members in multiplex conditions, particularly V␥2 vs V␥4 and V␥3 vs V␥5. A V␥fI consensus primer is probably preferable.
To our knowledge, this paper represents the first report of multi-fluorescent TCRG analysis. Monofluorescent analysis of TCRG rearrangements with high resolution analysis has been described but was not adapted for V␥ or J␥ typing. 17 By performing up to three multifluorescent run-off reactions (1 V␥ and 2 J␥) on multiplex PCR, it is possible to identify all V␥ and J␥ segments other than V␥12, which is rearranged very infrequently 2 and is rarely used in diagnostic PCR strategies. The sensitivity of these strategies was 99% (81/82) for J␥ identification and 96% (79/82) for V␥. The three undetected V␥ alleles included two V␥7 and one V␥4. The former are to be expected, since V␥7 can be detected with the V␥fI consensus primer but not with the V␥FluRO mix. Their negativity demonstrates the specificity of the V␥2/4, V␥3/5 and V␥8 fluorescent primers. V␥7 is used rarely (2/82 alleles in the present series) and can be screened for by specific PCR if desired.
No attempt was made here to distinguish V␥2 from V␥4 and V␥3 from V␥5 by fluorescent run-off, in view of the Ͼ95% homology. Despite this, the initial internal V␥2/4 INT-6FAM recognised V␥2 rearrangements preferentially, due to a G-C mismatch with V␥4 at position 15 of a 24-mer. We encountered an additional problem which appears to be due to a failure of amplification of occasional DNAs in the presence of labelled primers. FluRO of both alleles in 1/46 (2%) T-ALLs failed, when parallel amplification using the same unlabelled primers was successful. The fact that this was observed with two independent multiplex PCR, with both V␥ and J␥ segments on different alleles and with two different fluorophores suggest that it is DNA related. We postulate that DNA from certain patients may be particularly susceptible to inhibition (as in UPN 1613 and, to a lesser extent UPN 1314). It is noteworthy that these two patients had both undergone V␥3-J␥1/2 and V␥4-J␥1/2 rearrangements. This combination was only seen in one other patient. Recognition of this phenomenon can reduce misinterpretation of results.
Comparable assessment by monoplex PCR would require a total of 21 reactions per patient, although a sequential approach based on relative frequency of V␥ and J␥ utilisation would obviously reduce this number in the majority of cases. A possible alternative to the run-off strategies performed here would be to perform direct fluorescent analysis with similar V␥ and labelled J␥ primer mixes. This would reduce the number of analyses to two initial multiplex PCR with three differently labelled J␥ primers, with identification of V␥fl, V␥9, V␥10 and V␥11 on the basis of size and V␥fI subtyping as a third PCR with fluorescent V␥ primers, if desired. This approach would be justified for initial characterisation of material from patients destined for future molecular followup, such as ALL. It remains to be determined whether initial fluorescent analysis of all diagnostic samples will represent an improvement over EB PAGE.
Several laboratories limit rearrangement analysis to the most frequent combinations, commonly to V␥fI-J␥1/2, V␥fI-J␥P1/2 and V␥9-J␥1/2. This would allow detection of 70/81 (85%) of the alleles detected here. The number of non-informative cases would rise from one to four and those with a monoallelic rearrangement from eight to 14. While this does not have a major impact on the number of patients being followed by TCRG PCR, it does limit the number of available molecular targets. It is also conceivable that V␥10 and V␥11 usage will be more frequent in other T cell malignancies.
It should be emphasised that the multifluorescent run-off strategies described here are designed for the characterisation of major clonal rearrangements and not for improved detection of minor populations, particularly with regard to V␥ analysis. The more the TCRG repertoire is subdivided, the more difficult it becomes to separate clonal from oligoclonal samples, as demonstrated for the under-represented V␥-J␥ combinations, since the Gaussian distribution becomes more irregular.
High resolution fragment separation is extremely important in TCRG analysis since the junctional diversity is relatively limited and the different peaks in a polyclonal population are much more closely packed than for IGH rearrangements. This results from the fact that IGH PCR products demonstrate a 3 bp size distribution, since in-frame rearrangements are selected in virtually all B cells during lymphoid development, whereas TCRG rearrangements only undergo selection of inframe rearrangements in a minority of circulating T lymphocytes. TCRG PCR products therefore demonstrate a 1 bp size distribution. The increased resolution provided by FluRO analysis allowed identification of unsuspected bi-allelic rearrangements in 3/46 T-ALLs in the present series and increased precision in size identification of clonal populations, useful for follow-up. We did not attempt to exploit precision sizing for the identification, for example, of in-frame rearrangements. This should be possible, if appropriate size markers and electrophoretic conditions are used. Other techniques for obtaining high resolution of TCRG PCR products include denaturing-gradient gel electrophoresis, 18, 19 temperature-gradient gel electrophoresis 20 or single-stranded conformational polymorphism. 21 Preferential pairing of certain TCRG segments was observed: V␥2-5 paired almost exclusively with J␥1/2 (91%) whereas V␥8 and V␥11 paired frequently with J␥P1/2. The latter segment is known to rearrange preferentially to J␥-proximal V␥ segments.
22,23 J␥P1/2 rearrangements were moreover frequent in T-ALLs demonstrating monoallelic rearrangement, suggesting that this segment may decrease the incidence of rearrangement on the second allele, or that these rearrangements occur preferentially in a population of cells destined to shut down TCRG rearrangement capacity at an early stage. As previously described, 24 J␥P rearrangements were rare, only occurring in one, surface CD3-negative, T-ALL.
Recent studies using ASO-specific probes suggest that detection at complete remission of minor clonal populations at the 10 −3 level will identify approximately 10-15% of childhood ALL at a high risk of relapse and that 10 −2 may suffice at initial achievement of complete remission (approximately day 30). 11, 12 Our current analyses demonstrate that this level of detection should be possible using optimised direct fluorescent PCR, but that this is likely to be reproducibly achieved only by using V␥-J␥-specific strategies. The rapid V␥ and J␥ typing strategies described here should facilitate identification of appropriate follow-up primers. It is, however, noteworthy that multiplex fluorescence analysis, which led to a five-to 10-fold increase in sensitivity compared to EB PAGE analysis, gave a 5 × 10 −3 level of sensitivity in 5/6 alleles tested. It should be emphasised that the levels of sensitivity attained here are only possible if the exact size of the diagnostic peaks are known. This approach has the advantage of being universal and of allowing detection of novel or minor rearrangements not detected in the diagnostic sample. Clonal evolution between diagnosis and relapse occurs in approximately 10% of cases on at least one Ig/TCR rearrangement, with the incidence varying for the target gene. Such evolution should be less frequent in early remission samples. However, Evans et al 25 recently identified novel IGH rearrangements by monofluorescent genescan analysis in five of nine childhood ALLs demonstrating residual molecular positivity at week 20, including four which subsequently relapsed. We therefore conclude, that while V␥-J␥-specific strategies will provide the required sensitivity for detection of high risk patients, the reduced capacity to detect novel rearrangements is a limitation of this, and ASO, approaches. This can obviously be reduced by the use of multiple targets. We propose a combination of follow-up analysis by fluorescent multiplex (sensitivity 10 −2 -5 × 10
) for the detection of significant clonal evolution and optimised V␥-J␥-specific monoplex for detection of the diagnostic rearrangement(s) at the 5 × 10 −4 to 5 × 10 −3 level. The simplified approaches described here are obviously not capable of detecting patients in extremely good prognostic groups, as previously identified, 12 since a sensitivity of approximately 10 −5 is required. It is to be expected that minor residual leukaemic populations using rare V␥-J␥ combinations will be detected with greater sensitivity, due to less marked competition from polyclonal rearrangements, as observed for the V␥11 rearrangement here. The exclusion of this type of rearrangement in the selective TCR V␥-J␥ combination strategies mentioned above, may have a practical impact on the proportion of patients showing residual molecular positivity. Other variables affecting sensitivity include the position of the clonal peak relative to the polyclonal peaks, as demonstrated here. While these considerations should be borne in mind when analysing different follow-up series, they will probably represent a secondary effect when large patient series are examined.
Our data also demonstrate that TCRG utilisation is not significantly different in children and adults, suggesting that fluorescent strategies should be applicable with equivalent informativity and success in both clinical situations. This is in keeping with recent data from Ref. 24 25 The present study extends application of this type of technology to both T and B lineage ALL and provides a level of sensitivity which has recently been shown to have clinical relevance with techniques which are attainable in a routine molecular diagnostic laboratory with large-scale patient throughput. Their use should allow improved follow-up of patients with ALL or other disorders characterised by TCRG clonality.
